WNK3 inhibition suppressed PD-L1 expression in cancer cells, thereby increasing their susceptibility to CD8+ T cells, whereas in immune cells, it facilitated antitumorigenic cytokine secretion by CD8+ T cells. This evidence concerns the gene CD8A and cancer.